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In an attempt to better treatment
methodology for cervical cancer patients
who are at higher risk for responding poorly
to standard forms of treatment, research is
being conducted to develop more targeted
approaches to improve chances of recovery.

Results
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A potential factor worth investigating is the
tumor microenvironment and how the
diversity or presence of particular bacterium
may affect tumor response to treatment.
Lactobacillus Iners has been identified as a
species that may hinder a successful
response of a tumor to chemoradiation
treatment (CRT). This project seeks to
investigate the validity of this specific
effect.
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Purpose & Hypothesis
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For the SiHa cell line, colony formation of
cells exposed to Lactobacillus Iners also
exhibited a smaller percent survival in
comparison to the negative media control.
However, large standard deviations again
demonstrate that the presence of this bacteria
in the tumor microbiome has a limited effect
on the radio sensitization of tumor cells.
Interestingly, the difference in percent survival
becomes significant at higher doses which
may suggest that the sole presence of
Lactobacillus Iners may actually heighten
radiosensitivity to cisplatin.
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8 Supernatants/Media Controls
• L.C. ATCC, L.C. Patient 39, L. Iners
ATCC, L. Iners Patient 370, L. Iners
Patient 366
• MRS (Control), NYCIII (Control),
Media (Control)
Cell Lines and Cisplatin Dosages Used
• HeLa: 0, 1, 2, 3, 4, 5 (ug/mL)
(Removed after 1 hour)
• Cells Seeded: 100, 250, 500,
750, 1000, 1500
• SiHa: 0, 0.15, 0.3, 0.45, 0.6, 0.75
(ug/mL) (Removed after 4 hours)
• Cells Seeded: 100, 250, 500,
750, 1000, 1500
Incubation Periods
• HeLa: 10 days (7/9/21-7/19/21)
• SiHa: 14 days (7/8/21-7/22/21)
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SiHa-Iners Supernatants

We hypothesize that the presence of
Lactobacillus Iners supernatant will
decrease the radiosensitivity of tumor cells
to chemotherapy in both the HeLa and SiHa
cell lines.
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The purpose of this project is to gain a better
understanding of the relationship between
the tumor microenvironment and its ability
to influence tumor response to standard
forms of treatment for cervical cancers.
Understanding how the presence of different
strains of bacteria influence the efficacy of
chemotherapy will help improve the
efficacy of treatment in future patients.

Methods

For the HeLa cell line, colony formation of
cells exposed to Lactobacillus Iners exhibited
a smaller percent survival in comparison to
cells treated with the negative media control,
NYCIII. However, this slight trend is
inconclusive as overlapping standard
deviations suggest that the presence of L.
Iners may not have a significant effect on cell
recovery post treatment.
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The sole presence of Lactobacillus Iners in the
tumor microenvironment does not seem to
have its hypothesized effect on the ability of
cells to successfully respond to standard
chemoradiation treatment. Cells treated with
Lactobacillus Iners supernatant did not have a
more pronounced recovery when compared to
its negative media control.
Future experimentation is needed to compare
the difference between the presence of
Lactobacillus Iners and Lactobacillus
Crispatus in the tumor microbiome in addition
to increased cell exposure to higher doses of
cisplatin. Furthermore, clinical findings that
suggest of a relationship between the presence
of Lactobacillus Iners and decreased tumor
radiosensitivity to chemotherapy may be a
result of a combination of factors rather than
the sole existence of Lactobacillus Iners in the
tumor microenvironment.

